Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A case of localized tracheobronchial relapsing polychondritis with positive matrilin-1 staining.

Makiguchi T, Koarai A, Inoue C, Aoyama Y, Hirano T, Ohe T, Ichikawa T, Shishikura Y, Komuro H, Tsukita Y, Tode N, Numakura T, Saito T, Sato T, Mitsuhashi Y, Tamada T, Sugiura H, Ichinose M.

BMC Rheumatol. 2020 Jan 29;4:1. doi: 10.1186/s41927-019-0103-6. eCollection 2020.

2.

Increase in circulating ACE-positive endothelial microparticles during acute lung injury.

Takei Y, Yamada M, Saito K, Kameyama Y, Sugiura H, Makiguchi T, Fujino N, Koarai A, Toyama H, Saito K, Ejima Y, Kawazoe Y, Kudo D, Kushimoto S, Yamauchi M, Ichinose M.

Eur Respir J. 2019 Oct 17;54(4). pii: 1801188. doi: 10.1183/13993003.01188-2018. Print 2019 Oct.

PMID:
31320458
3.

Nitrosative stress in patients with asthma-chronic obstructive pulmonary disease overlap.

Kyogoku Y, Sugiura H, Ichikawa T, Numakura T, Koarai A, Yamada M, Fujino N, Tojo Y, Onodera K, Tanaka R, Sato K, Sano H, Yamanaka S, Itakura K, Mitsune A, Tamada T, Akaike T, Ichinose M.

J Allergy Clin Immunol. 2019 Oct;144(4):972-983.e14. doi: 10.1016/j.jaci.2019.04.023. Epub 2019 May 9.

PMID:
31077687
4.

Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinib.

Hirano T, Koarai A, Ichikawa T, Sato T, Ohe T, Ichinose M.

BMC Cancer. 2018 Oct 19;18(1):995. doi: 10.1186/s12885-018-4913-5.

5.

Correction to: Oxidative stress enhances the expression of IL-33 in human airway epithelial cells.

Aizawa H, Koarai A, Shishikura Y, Yanagisawa S, Yamaya M, Sugiura H, Numakura T, Yamada M, Ichikawa T, Fujino N, Noda M, Okada Y, Ichinose M.

Respir Res. 2018 Jun 12;19(1):116. doi: 10.1186/s12931-018-0817-9.

6.

Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease.

Tanaka R, Sugiura H, Yamada M, Ichikawa T, Koarai A, Fujino N, Yanagisawa S, Onodera K, Numakura T, Sato K, Kyogoku Y, Sano H, Yamanaka S, Okazaki T, Tamada T, Miura M, Takahashi T, Ichinose M.

Int J Chron Obstruct Pulmon Dis. 2018 Apr 24;13:1333-1342. doi: 10.2147/COPD.S157035. eCollection 2018.

7.

Possible involvement of acetylcholine-mediated inflammation in airway diseases.

Koarai A, Ichinose M.

Allergol Int. 2018 Oct;67(4):460-466. doi: 10.1016/j.alit.2018.02.008. Epub 2018 Mar 28. Review.

8.

Oxidative stress enhances the expression of IL-33 in human airway epithelial cells.

Aizawa H, Koarai A, Shishikura Y, Yanagisawa S, Yamaya M, Sugiura H, Numakura T, Yamada M, Ichikawa T, Fujino N, Noda M, Okada Y, Ichinose M.

Respir Res. 2018 Mar 27;19(1):52. doi: 10.1186/s12931-018-0752-9. Erratum in: Respir Res. 2018 Jun 12;19(1):116.

9.

Production of reactive persulfide species in chronic obstructive pulmonary disease.

Numakura T, Sugiura H, Akaike T, Ida T, Fujii S, Koarai A, Yamada M, Onodera K, Hashimoto Y, Tanaka R, Sato K, Shishikura Y, Hirano T, Yanagisawa S, Fujino N, Okazaki T, Tamada T, Hoshikawa Y, Okada Y, Ichinose M.

Thorax. 2017 Dec;72(12):1074-1083. doi: 10.1136/thoraxjnl-2016-209359. Epub 2017 Jul 19.

PMID:
28724639
10.

Decrease in an anti-ageing factor, growth differentiation factor 11, in chronic obstructive pulmonary disease.

Onodera K, Sugiura H, Yamada M, Koarai A, Fujino N, Yanagisawa S, Tanaka R, Numakura T, Togo S, Sato K, Kyogoku Y, Hashimoto Y, Okazaki T, Tamada T, Kobayashi S, Yanai M, Miura M, Hoshikawa Y, Okada Y, Suzuki S, Ichinose M.

Thorax. 2017 Oct;72(10):893-904. doi: 10.1136/thoraxjnl-2016-209352. Epub 2017 Apr 28.

PMID:
28455454
11.

Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.

Tode N, Kikuchi T, Sakakibara T, Hirano T, Inoue A, Ohkouchi S, Tamada T, Okazaki T, Koarai A, Sugiura H, Niihori T, Aoki Y, Nakayama K, Matsumoto K, Matsubara Y, Yamamoto M, Watanabe A, Nukiwa T, Ichinose M.

Cancer Sci. 2017 Jun;108(6):1263-1270. doi: 10.1111/cas.13233. Epub 2017 May 11.

12.

[Case Report ; A case of infection of Chlamydophila pneumoniae with ARDS].

Tsukita Y, Yamada M, Ohe T, Ito S, Kobayashi M, Tamai T, Koarai A, Tamada T, Sugiura H, Ichinose M.

Nihon Naika Gakkai Zasshi. 2016 Dec;105(12):2426-2431. Japanese. No abstract available.

PMID:
30646442
13.

Extracellular ATP is involved in dsRNA-induced MUC5AC production via P2Y2R in human airway epithelium.

Shishikura Y, Koarai A, Aizawa H, Yamaya M, Sugiura H, Watanabe M, Hashimoto Y, Numakura T, Makiguti T, Abe K, Yamada M, Kikuchi T, Hoshikawa Y, Okada Y, Ichinose M.

Respir Res. 2016 Sep 27;17(1):121.

14.

Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis.

Makiguchi T, Yamada M, Yoshioka Y, Sugiura H, Koarai A, Chiba S, Fujino N, Tojo Y, Ota C, Kubo H, Kobayashi S, Yanai M, Shimura S, Ochiya T, Ichinose M.

Respir Res. 2016 Sep 5;17(1):110. doi: 10.1186/s12931-016-0427-3.

15.

27-Hydroxycholesterol accelerates cellular senescence in human lung resident cells.

Hashimoto Y, Sugiura H, Togo S, Koarai A, Abe K, Yamada M, Ichikawa T, Kikuchi T, Numakura T, Onodera K, Tanaka R, Sato K, Yanagisawa S, Okazaki T, Tamada T, Kikuchi T, Hoshikawa Y, Okada Y, Ichinose M.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1028-41. doi: 10.1152/ajplung.00351.2015. Epub 2016 Apr 1.

16.

Possible role of Krüppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease.

Abe K, Sugiura H, Hashimoto Y, Ichikawa T, Koarai A, Yamada M, Numakura T, Onodera K, Tanaka R, Sato K, Yanagisawa S, Okazaki T, Tamada T, Kikuchi T, Ichinose M.

Respir Res. 2016 Jan 20;17:7. doi: 10.1186/s12931-016-0322-y.

17.

Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells.

Kanai K, Koarai A, Shishikura Y, Sugiura H, Ichikawa T, Kikuchi T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Respir Investig. 2015 Jul;53(4):137-48. doi: 10.1016/j.resinv.2015.01.007. Epub 2015 Mar 12.

PMID:
26100173
18.

TLR3 activation augments matrix metalloproteinase production through reactive nitrogen species generation in human lung fibroblasts.

Ichikawa T, Sugiura H, Koarai A, Minakata Y, Kikuchi T, Morishita Y, Oka A, Kanai K, Kawabata H, Hiramatsu M, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Yamamoto N, Ichinose M.

J Immunol. 2014 Jun 1;192(11):4977-88. doi: 10.4049/jimmunol.1302919. Epub 2014 Apr 23.

19.

Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease.

Minakata Y, Sugino A, Kanda M, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Sugiura H, Matsunaga K, Ichinose M.

Respir Investig. 2014 Jan;52(1):41-8. doi: 10.1016/j.resinv.2013.06.002. Epub 2013 Jul 18.

PMID:
24388370
20.

Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD.

Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K, Ichikawa T, Furukawa K, Ichinose M.

J Breath Res. 2013 Dec;7(4):046002. doi: 10.1088/1752-7155/7/4/046002. Epub 2013 Oct 4.

PMID:
24091810
21.

Successful crizotinib retreatment after crizotinib-induced interstitial lung disease.

Yanagisawa S, Inoue A, Koarai A, Ono M, Tamai T, Ichinose M.

J Thorac Oncol. 2013 Aug;8(8):e73-4. doi: 10.1097/JTO.0b013e318293dfc1. No abstract available.

22.

Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma.

Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K, Ichikawa T, Furukawa K, Ichinose M.

Respir Investig. 2013 Jun;51(2):84-91. doi: 10.1016/j.resinv.2013.01.002. Epub 2013 Mar 26.

PMID:
23790736
23.

25-hydroxycholesterol promotes fibroblast-mediated tissue remodeling through NF-κB dependent pathway.

Ichikawa T, Sugiura H, Koarai A, Kikuchi T, Hiramatsu M, Kawabata H, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Exp Cell Res. 2013 May 1;319(8):1176-86. doi: 10.1016/j.yexcr.2013.02.014. Epub 2013 Feb 26.

PMID:
23485764
24.

A role for M(2) and M(3) muscarinic receptors in the contraction of rat and human small airways.

Brown SM, Koarai A, Sturton RG, Nicholson AG, Barnes PJ, Donnelly LE.

Eur J Pharmacol. 2013 Feb 28;702(1-3):109-15. doi: 10.1016/j.ejphar.2013.01.054. Epub 2013 Feb 8.

PMID:
23396230
25.

25-Hydroxycholesterol enhances cytokine release and Toll-like receptor 3 response in airway epithelial cells.

Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Kikuchi T, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Respir Res. 2012 Jul 31;13:63.

26.

Cigarette smoke augments the expression and responses of toll-like receptor 3 in human macrophages.

Koarai A, Yanagisawa S, Sugiura H, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Respirology. 2012 Aug;17(6):1018-25. doi: 10.1111/j.1440-1843.2012.02198.x.

PMID:
22591330
27.

Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics.

Matsunaga K, Yanagisawa S, Hirano T, Ichikawa T, Koarai A, Akamatsu K, Sugiura H, Minakata Y, Matsunaga K, Kawayama T, Ichinose M.

Clin Exp Allergy. 2012 May;42(5):775-81. doi: 10.1111/j.1365-2222.2011.03945.x.

PMID:
22515393
28.

Validation of the triaxial accelerometer for the evaluation of physical activity in Japanese patients with COPD.

Kanda M, Minakata Y, Matsunaga K, Sugiura H, Hirano T, Koarai A, Akamatsu K, Ichikawa T, Ichinose M.

Intern Med. 2012;51(4):369-75. Epub 2012 Feb 15.

29.

Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease.

Sugiura H, Koarai A, Ichikawa T, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Yanagisawa S, Furusawa M, Uno Y, Yamasaki M, Satomi Y, Ichinose M.

Respirology. 2012 Apr;17(3):533-40. doi: 10.1111/j.1440-1843.2012.02136.x.

PMID:
22295989
30.

Inhibitory effects of theophylline on the peroxynitrite-augmented release of matrix metalloproteinases by lung fibroblasts.

Sugiura H, Kawabata H, Ichikawa T, Koarai A, Yanagisawa S, Kikuchi T, Minakata Y, Matsunaga K, Nakanishi M, Hirano T, Akamatsu K, Furukawa K, Ichinose M.

Am J Physiol Lung Cell Mol Physiol. 2012 Apr 15;302(8):L764-74. doi: 10.1152/ajplung.00342.2011. Epub 2012 Jan 27. Erratum in: Am J Physiol Lung Cell Mol Physiol. 2013 Sep;305(5):L404.

31.

Increase of 27-hydroxycholesterol in the airways of patients with COPD: possible role of 27-hydroxycholesterol in tissue fibrosis.

Kikuchi T, Sugiura H, Koarai A, Ichikawa T, Minakata Y, Matsunaga K, Nakanishi M, Hirano T, Akamatsu K, Yanagisawa S, Furukawa K, Kawabata H, Ichinose M.

Chest. 2012 Aug;142(2):329-337. doi: 10.1378/chest.11-2091.

PMID:
22281802
32.

Validation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary disease.

Sugino A, Minakata Y, Kanda M, Akamatsu K, Koarai A, Hirano T, Sugiura H, Matsunaga K, Ichinose M.

Respiration. 2012;83(4):300-7. doi: 10.1159/000330046. Epub 2011 Sep 9.

33.

Expression of muscarinic receptors by human macrophages.

Koarai A, Traves SL, Fenwick PS, Brown SM, Chana KK, Russell RE, Nicholson AG, Barnes PJ, Donnelly LE.

Eur Respir J. 2012 Mar;39(3):698-704. doi: 10.1183/09031936.00136710. Epub 2011 Sep 1.

34.

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Akamatsu K, Matsunaga K, Sugiura H, Koarai A, Hirano T, Minakata Y, Ichinose M.

Front Pharmacol. 2011 Jul 18;2:36. doi: 10.3389/fphar.2011.00036. eCollection 2011.

35.

Increase of nitrosative stress in patients with eosinophilic pneumonia.

Furukawa K, Sugiura H, Matsunaga K, Ichikawa T, Koarai A, Hirano T, Yanagisawa S, Minakata Y, Akamatsu K, Kanda M, Nishigai M, Ichinose M.

Respir Res. 2011 Jun 17;12:81. doi: 10.1186/1465-9921-12-81.

36.

Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects.

Matsunaga K, Hirano T, Akamatsu K, Koarai A, Sugiura H, Minakata Y, Ichinose M.

Allergol Int. 2011 Sep;60(3):331-7. doi: 10.2332/allergolint.10-OA-0277. Epub 2011 Apr 25.

37.

High COPD prevalence in patients with liver disease.

Minakata Y, Ueda H, Akamatsu K, Kanda M, Yanagisawa S, Ichikawa T, Koarai A, Hirano T, Sugiura H, Matsunaga K, Ichinose M.

Intern Med. 2010;49(24):2687-91. Epub 2010 Dec 15.

38.

Clinical application of exhaled breath condensate analysis in asthma: prediction of FEV1 improvement by steroid therapy.

Matsunaga K, Ichikawa T, Yanagisawa S, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M.

Respiration. 2009;78(4):393-8. doi: 10.1159/000243551. Epub 2009 Sep 29.

PMID:
19786734
39.

Oxidative stress enhances toll-like receptor 3 response to double-stranded RNA in airway epithelial cells.

Koarai A, Sugiura H, Yanagisawa S, Ichikawa T, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Ichinose M.

Am J Respir Cell Mol Biol. 2010 Jun;42(6):651-60. doi: 10.1165/rcmb.2008-0345OC. Epub 2009 Jul 13.

40.

Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects.

Yanagisawa S, Koarai A, Sugiura H, Ichikawa T, Kanda M, Tanaka R, Akamatsu K, Hirano T, Matsunaga K, Minakata Y, Ichinose M.

Respir Res. 2009 Jun 15;10:50. doi: 10.1186/1465-9921-10-50.

41.

Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy.

Matsunaga K, Yanagisawa S, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M.

Allergol Int. 2009 Mar;58(1):89-96. doi: 10.2332/allergolint.08-OA-0014. Epub 2009 Jan 25.

42.

Activation of Toll-like receptor 3 augments myofibroblast differentiation.

Sugiura H, Ichikawa T, Koarai A, Yanagisawa S, Minakata Y, Matsunaga K, Hirano T, Akamatsu K, Ichinose M.

Am J Respir Cell Mol Biol. 2009 Jun;40(6):654-62. doi: 10.1165/rcmb.2008-0371OC. Epub 2008 Nov 6.

PMID:
18988918
43.

Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation.

Ichikawa T, Sugiura H, Koarai A, Yanagisawa S, Kanda M, Hayata A, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Am J Physiol Lung Cell Mol Physiol. 2008 Nov;295(5):L800-8. doi: 10.1152/ajplung.90264.2008. Epub 2008 Sep 12.

44.

The possible role of hematopoietic cell kinase in the pathophysiology of COPD.

Yanagisawa S, Sugiura H, Yokoyama T, Yamagata T, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M.

Chest. 2009 Jan;135(1):94-101. doi: 10.1378/chest.07-3020. Epub 2008 Aug 21.

PMID:
18719065
45.

Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics.

Matsunaga K, Kanda M, Hayata A, Yanagisawa S, Ichikawa T, Akamatsu K, Koarai A, Hirano T, Sugiura H, Minakata Y, Ichinose M.

Intern Med. 2008;47(12):1107-12. Epub 2008 Jun 16.

46.

[Role of acetylcholine in COPD].

Koarai A.

Nihon Kokyuki Gakkai Zasshi. 2008 Apr;46(4):346-50. Review. Japanese. No abstract available.

PMID:
18517002
47.

Prevalence of COPD in primary care clinics: correlation with non-respiratory diseases.

Minakata Y, Sugiura H, Yamagata T, Yanagisawa S, Ichikawa T, Koarai A, Akamatsu K, Hirano T, Matsunaga K, Ichinose M.

Intern Med. 2008;47(2):77-82. Epub 2008 Jan 15.

48.

Nitrative stress in refractory asthma.

Sugiura H, Komaki Y, Koarai A, Ichinose M.

J Allergy Clin Immunol. 2008 Feb;121(2):355-60. Epub 2007 Dec 26.

PMID:
18158173
49.

Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung.

Tomaki M, Sugiura H, Koarai A, Komaki Y, Akita T, Matsumoto T, Nakanishi A, Ogawa H, Hattori T, Ichinose M.

Pulm Pharmacol Ther. 2007;20(5):596-605. Epub 2006 Jul 11.

PMID:
16919984
50.

Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways.

Komaki Y, Sugiura H, Koarai A, Tomaki M, Ogawa H, Akita T, Hattori T, Ichinose M.

Pulm Pharmacol Ther. 2005;18(4):297-302.

PMID:
15777613

Supplemental Content

Loading ...
Support Center